Search Results
Facet (Page)
Refine Your Search
Audiences
Content Formats
Sections
Divisions
Event
The Excellence in Clinical Research Seminar Series is designed to facilitate clinical research in the rare disease space with a focus on aspects of regulatory medicine and clinical trials in Mendelian disorders.
Event
On March 12-16, 2024, the National Human Genome Research Institute (NHGRI) will participate in the 2024 ACMG Annual Clinical Genetics Meeting - an annual medical and scientific conference continues to provide groundbreaking research and the latest advances in medical genetics, genomics and personalized medicine.
… in the All of Us Research Program Clinical Genetics and Therapeutics Session A March 14, 2024, 4:15 – 5:45 p.m … in Patients with Alkaptonuria Biochemical/Metabolic and Therapeutics March 14, 2024, 4:15 – 5:45 p.m MTCC-701 … Creatine Deficiency Syndromes Biochemical/Metabolic and Therapeutics … Poster Presentations  No. Title P006 …
Staff
Dr. Michael Erdos is an Associate Investigator in the Molecular Genetics Section of the Center for Precision Health Research.
… translational research to identify and validate potential therapeutics for the rare premature-aging disease, Hutchinson … useful model for preclinical investigation of potential therapeutics, particularly for genetic therapies, because the … human LMNA DNA sequence. In the realm of small molecule therapeutics, farnesyl transferase inhibitors (FTIs) target …
Fact Sheets
Cloning describes a number of different processes that can be used to produce genetically identical copies of a biological entity.
News Release
NHGRI has appointed Neil Hanchard, M.D., Ph.D., as a clinical investigator within the Medical Genomics and Metabolic Genetics Branch (MGMGB) in the Division of Intramural Research. Dr. Hanchard will head the Childhood Complex Disease Genomics Section within the MGMGB.
Graduate Medical Education
An opportunity for a 4-to-8-week elective in the National Human Genome Research Institute (NHGRI) at the NIH Clinical Center in Bethesda, MD.
… Informatics Cardiology Clinical Pharmacology and Therapeutics for Senior Medical Students Critical Care …
The Genomics Landscape
In the November 2024 issue of The Genomics Landscape, NHGRI Director Eric Green spotlights the History of Genomics Program, which has long worked to make various materials related to the history of genomics accessible to the public.
For Patients and Families
Por lo general, se considera que una enfermedad es rara cuando afecta a menos de 200,000 personas en los Estados Unidos en cualquier momento dado.
… de Tratamientos para enfermedades raras y desatendidas ( Therapeutics for Rare and Neglected Diseases , TRND), a fin …
Staff
William J. Pavan, Ph.D. is the chief of NHGRI's Genetic Disease Research Branch.
… therapeutic compounds via high-throughput screens, its Therapeutics for Rare and Neglected Diseases program to …
Event
The Advances in Genomic Technology Development (AGTD) 2023 Annual Meeting was hosted by the Technology Development Coordinating Center (TDCC) in-person and virtually from Tuesday, June 6, until Thursday, June 8, at The Sanford Consortium for Regenerative Medicine, La Jolla, CA.
… San Diego 10:30 a.m. Fernando Aleman, Ph.D., Navega Therapeutics Aaron Parker, Ph.D., J.D., Bristol Myers Squibb … Gonzales, Ph.D., Goodwin Katannya Kapeli, Ph.D., Trotana Therapeutics aclyn Einstein, Ph.D., Trotana Therapeutics Sergio Duron Ph.D., Enlaza Therapeutics Adam …